Cover Image
市場調查報告書

中國的分子診斷市場、檢查數量的預測

China Molecular Diagnostics Market, Test Volume & Forecast

出版商 Renub Research 商品編碼 344768
出版日期 內容資訊 英文 84 Pages; 55 Figures; 13 Tables
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的分子診斷市場、檢查數量的預測 China Molecular Diagnostics Market, Test Volume & Forecast
出版日期: 2015年11月06日 內容資訊: 英文 84 Pages; 55 Figures; 13 Tables
簡介

中國的中分子診斷部門是10億美元規模的產業,年年迅速發展。在國內未來市場中隱藏著非常大的可能性,預計從2015年到2019年,將進行3億件以上的分子診斷檢驗。

本報告提供中國的分子診斷的市場相關調查、市場規模及檢查數量的變化與預測、各用途的詳細分析、市場成長的推進因素及課題分析、主要經營者簡介等彙整資料。

第1章 摘要整理

第2章 中國的分子診斷市場、檢查數量的預測

  • 中國的分子診斷市場變化與預測
  • 中國的分子診斷檢查數量的變化與預測

第3章 中國的分子診斷市場、檢查數量的市場佔有率分析

  • 中國的分子診斷市場佔有率:變化與預測
  • 各用途佔有率的變化與預測
  • 中國的分子診斷的檢查數量的市場佔有率:變化與預測
  • 各檢查數量用途佔有率:變化與預測

第4章 中國的分子診斷檢查數量的變化與預測:各用途

  • 癌症的分子診斷檢查數量的佔有率:變化與預測
  • 癌症檢查數量的變化與預測
    • 乳癌
    • 直腸癌
    • 前列腺癌
  • 感染疾病的分子診斷檢查數量的佔有率:變化與預測
  • 傳染病檢查數量的變化與預測
    • 病毒檢驗
    • HPV檢驗
  • 遺傳基因的分子檢查數量的佔有率:變化與預測
  • 遺傳基因檢查數量的變化與預測
    • 血液篩檢檢驗
    • HLA檢驗

第5章 中國的分子診斷市場預測:各用途

  • 癌症的分子診斷檢驗市場佔有率:變化與預測
  • 癌症檢驗市場變化與預測
    • 乳癌
    • 直腸癌
    • 前列腺癌
  • 感染疾病的分子診斷檢驗市場佔有率:變化與預測
  • 傳染病檢查市場變化與預測
    • 病毒檢驗
    • HPV檢驗
  • 遺傳基因的分子診斷檢驗市場佔有率:變化與預測
  • 遺傳基因檢驗市場變化與預測
    • 血液篩檢檢驗
    • HLA檢驗

第6章 成長推進因素

  • 中產階級對高品質醫療保健產品的需求擴大
  • 中國的感染疾病診斷領域的急劇發展

第7章 課題

  • 政府支援不足、一般認知度低、償付方案的未整備
  • 有技術的人力資源不足

第8章 主要民間臨床實驗室、診斷服務企業簡介

  • Zhejiang Di'an Diagnostics Technology Co., Ltd.
  • ADICON Clinical Laboratories (民間)
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global (民間)
  • BGI-Shenzhen
  • OriGene Technologies
    • 企業概要
    • 產品與服務

圖表

目錄

China Molecular Diagnostics is a Billion dollar industry and its growing year on year rapidly. Molecular diagnostics holds immense potential in future of China Diagnostics Sector. It is predicted that China will perform over 300 Million molecular diagnostic tests during the forecasting period 2015 - 2019. Infectious disease and Oncology Testing both have almost equal share in China Molecular Diagnostics Sector. However in further sub-segmenting of molecular diagnostics market share perspective Virology Cancer Test holds the highest market share followed by Colorectal cancer and Breast Cancer Test.

Rising demand from middle class for high quality healthcare products, rapid development in the diagnosis of infectious diseases and increasing number of private hospitals are some of the growth drivers which is fueling this sector. However industry faces some kind of challenges such as shortage of lab technicians, lack of expertise in advanced technology in the local companies etc.

This is the 5th report on Molecular Diagnostics industry published by Renub Research. This report titled “China Molecular Diagnostics Market, Test Volume & Forecast” provides a comprehensive assessment of the fast-evolving, high-growth China Molecular diagnostics market.

This 84 page report with 55 Figures and 13 Tables studies the China Molecular Diagnostic market from 4 view points:

  • 1) Market & Forecast
  • 2) Application Wise Market & Forecast
  • 3) Application Wise Test Volume & Forecast
  • 4) Profiles of Select Private Clinical Labs & Diagnostic Services Companies

DATA SOURCES

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephonic interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Table of Contents

1. Executive Summary

2. China Molecular Diagnostic Market & Test Volume Forecast

  • 2.1. China Molecular Diagnostic Market (2010-2019)
  • 2.2. China Molecular Diagnostic Test Volume (2010-2019)

3. China Molecular Diagnostic Market & Test Volume Share Analysis

  • 3.1. China Molecular Diagnostic Market Share (2010-2019)
  • 3.2. China Molecular Diagnostic Application Market Share (2010-2019)
  • 3.3. China Molecular Diagnostic Test Volume Share (2010-2019)
  • 3.4. China Molecular Diagnostic Test Volume Application Share (2010-2019)

4. China Molecular Diagnostic Test Volume-Application Wise (2010-2019)

  • 4.1. China Molecular Oncology Test Volume Share (2010-2019)
  • 4.2. Oncology Test Volume (2010-2019)
    • 4.2.1. Breast Cancer Test Volume (2010-2019)
    • 4.2.2. Colorectal Cancer Test Volume (2010-2019)
    • 4.2.3. Prostate Cancer Test Volume (2010-2019)
  • 4.3. China Molecular Infectious Disease Test Volume Share (2010-2019)
  • 4.4. Infectious Disease Test Volume (2010-2019)
    • 4.4.1. Virology Test Volume (2010-2019)
    • 4.4.2. HPV Test Volume (2010-2019)
  • 4.5. China Molecular Genetic Test Volume Share (2010-2019)
  • 4.6. Genetic Test Volume (2010-2019)
    • 4.6.1. Blood Screening Test Volume (2010-2019)
    • 4.6.2. HLA Test Volume (2010-2019)

5. China Molecular Diagnostic Market & Forecast-Application Wise (2010-2019)

  • 5.1. China Molecular Oncology Test Market Share (2010-2019)
  • 5.2. Oncology Testing Market (2010-2019)
    • 5.2.1. Breast Cancer Testing Market (2010-2019)
    • 5.2.2. Colorectal Cancer Testing Market (2010-2019)
    • 5.2.3. Prostate Cancer Testing Market (2010-2019)
  • 5.3. China Molecular Infectious Disease Test Market Share (2010-2019)
  • 5.4. Infectious Disease Testing Market (2010-2019)
    • 5.4.1. Virology Testing Market (2010-2019)
    • 5.4.2. HPV Testing Market (2010-2019)
  • 5.5. China Molecular Genetic Test Market Share (2010-2019)
  • 5.6. Genetic Testing Market (2010-2019)
    • 5.6.1. Blood Screening Market (2010-2019)
    • 5.6.2. HLA Testing Market (2010-2019)

6. Growth Drivers

  • 6.1. Increasing Demand from Middle Class for High Quality Healthcare Products
  • 6.2. Rapid Development in the Diagnosis of Infectious Diseases in China

7. Challenges

  • 7.1. Lack of Government Support, Public Awareness & Reimbursement Schemes for Molecular Diagnostics test
  • 7.2. Shortage of Skilled Technicians in China

8. Profiles of Select Private Clinical Labs and Diagnostic Services Companies

  • 8.1. Zhejiang Di'an Diagnostics Technology Co., Ltd.
    • 8.1.1. Company Overview
    • 8.1.2. Products and Services Offered by Di'an
  • 8.2. ADICON Clinical Laboratories (Privately held)
    • 8.2.1. Company Overview
    • 8.2.2. Products and Services Offered by ADICON
  • 8.3. Guangzhou Kingmed Diagnostics Center Co. Ltd.
    • 8.3.1. Company Overview
    • 8.3.2. Products and Services Offered by Kingmed
  • 8.4. Kindstar Global (Privately held)
    • 8.4.1. Company Overview
    • 8.4.2. Products and Services Offered by Kindstar
  • 8.5. BGI-Shenzhen
    • 8.5.1. Company Overview
    • 8.5.2. BGI's Innovative Approach
  • 8.6. OriGene Technologies
    • 8.6.1. Company Overview
    • 8.6.2. Products and Services Offered by OriGene

LIST OF FIGURES

  • Table 3-1: China - Molecular Diagnostic Application Market Share (Percent), 2010 - 2014
  • Table 3-2: China - Forecast for Molecular Diagnostic Application Market Share (Percent), 2015 - 2019
  • Table 3-3: China - Molecular Diagnostic Test Volume Application Share (Percent), 2010 - 2014
  • Table 3-4: China - Forecast for Molecular Diagnostic Test Volume Application Share (Percent), 2015 - 2019
  • Table 4-1: China - Molecular Infectious Disease Test Volume Share (Percent), 2010 - 2014
  • Table 4-2: China - Forecast for Molecular Infectious Disease Test Volume Share (Percent), 2015 - 2019.
  • Table 4-3: China - Molecular Genetic Test Volume Share (Percent), 2010 - 2014
  • Table 4-4: China - Forecast for Molecular Genetic Test Volume Share (Percent), 2015 - 2019
  • Table 5-1: China - Molecular Infectious Disease Test Market Share (Percent), 2010 - 2014
  • Table 5-2: China - Forecast for Molecular Infectious Disease Test Market Share (Percent), 2015 - 2019
  • Table 5-3: China - Molecular Genetic Test Market Share (Percent), 2010 - 2014
  • Table 5-4: China - Forecast for Molecular Genetic Test Market Share (Percent), 2015 - 2019
  • Table 6-1: China - Major Diagnostic Reagent R&D and Manufacturing Companies in Infectious Diseases, 2010
Back to Top